Application of PepFect Peptides for the Delivery of Splice-Correcting Oligonucleotides

Methods in Molecular Biology

Volumn 683, Issue , 2011, Pages 361-373

  EL Andaloussi, Samir ^a   Lehto, Taavi ^b   Lundin, Per ^a   Langel, Ülo ^a,b  

^a STOCKHOLM UNIVERSITY   (Sweden)

^b UNIVERSITY OF TARTU   (Estonia)

Author keywords

Cell penetrating peptides; Co incubation; Oligonucleotide delivery; PepFect; Splice correction; Transfection

Indexed keywords

CELL PENETRATING PEPTIDE; OLIGONUCLEOTIDE; STEARIC ACID; STEARIC ACID DERIVATIVE;

AMINO ACID SEQUENCE; ARTICLE; CHEMISTRY; GENETICS; HELA CELL; HUMAN; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; RNA SPLICING;

AMINO ACID SEQUENCE; BASE SEQUENCE; CELL-PENETRATING PEPTIDES; HELA CELLS; HUMANS; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDES; RNA SPLICE SITES; RNA SPLICING; STEARIC ACIDS;

EID: 79952199122     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-60761-919-2_26     Document Type: Chapter

References (25)

1. Faustino, N. A., and Cooper, T. A. (2003) Pre-mRNA splicing and human disease, Genes Dev 17, 419–437.
2. Sazani, P., and Kole, R. (2003) Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing, J Clin Invest 112, 481–486.
3. Garcia-Blanco, M. A., Baraniak, A. P., and Lasda, E. L. (2004) Alternative splicing in disease and therapy, Nat Biotechnol 22, 535–546.
4. Pajares, M. J., Ezponda, T., Catena, R., Calvo, A., Pio, R., and Montuenga, L. M. (2007) Alternative splicing: an emerging topic in molecular and clinical oncology, Lancet Oncol 8, 349–357.
5. Sierakowska, H., Sambade, M. J., Agrawal, S., and Kole, R. (1996) Repair of thalassemic human beta-globin mRNA in mammalian cells by antisense oligonucleotides, Proc Natl Acad Sci USA 93, 12840–12844.
6. Sazani, P., Gemignani, F., Kang, S. H., Maier, M. A., Manoharan, M., Persmark, M., Bortner, D., and Kole, R. (2002) Systemically delivered antisense oligomers upregulate gene expression in mouse tissues, Nat Biotechnol 20, 1228–1233.
7. Lu, Q. L., Mann, C. J., Lou, F., Bou-Gharios, G., Morris, G. E., Xue, S. A., Fletcher, S., Partridge, T. A., and Wilton, S. D. (2003) Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse, Nat Med 9, 1009–1014.
8. Ivanova, G. D., Arzumanov, A., Abes, R., Yin, H., Wood, M. J., Lebleu, B., and Gait, M. J. (2008) Improved cell-penetrating peptide-PNA conjugates for splicing redirection in HeLa cells and exon skipping in mdx mouse muscle, Nucleic Acids Res 36, 6418–6428.
9. Fletcher, S., Honeyman, K., Fall, A. M., Harding, P. L., Johnsen, R. D., Steinhaus, J. P., Moulton, H. M., Iversen, P. L., and Wilton, S. D. (2007) Morpholino oligomer-mediated exon skipping averts the onset of dystrophic pathology in the mdx mouse, Mol Ther 15, 1587–1592.
10. van Deutekom, J. C., Janson, A. A., Ginjaar, I. B., Frankhuizen, W. S., Aartsma-Rus, A., Bremmer-Bout, M., den Dunnen, J. T., Koop, K., van der Kooi, A. J., Goemans, N. M., de Kimpe, S. J., Ekhart, P. F., Venneker, E. H., Platenburg, G. J., Verschuuren, J. J., and van Ommen, G. J. (2007) Local dystrophin restoration with antisense oligonucleotide PRO051, N Engl J Med 357, 2677–2686.
11. Aartsma-Rus, A., Fokkema, I., Verschuuren, J., Ginjaar, I., van Deutekom, J., van Ommen, G. J., and den Dunnen, J. T. (2009) Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations, Hum Mutat 30, 293–299.
12. Liu, D., Ren, T., and Gao, X. (2003) Cationic transfection lipids, Curr Med Chem 10, 1307–1315.
13. Scheule, R. K., St George, J. A., Bagley, R. G., Marshall, J., Kaplan, J. M., Akita, G. Y., Wang, K. X., Lee, E. R., Harris, D. J., Jiang, C., Yew, N. S., Smith, A. E., and Cheng, S. H. (1997) Basis of pulmonary toxicity associated with cationic lipid-mediated gene transfer to the mammalian lung, Hum Gene Ther 8, 689–707.
14. Abes, R., Moulton, H. M., Clair, P., Yang, S. T., Abes, S., Melikov, K., Prevot, P., Youngblood, D. S., Iversen, P. L., Chernomordik, L. V., and Lebleu, B. (2008) Delivery of steric block morpholino oligomers by (R-X-R)4 peptides: structure-activity studies, Nucleic Acids Res 36, 6343–6354.
15. El-Andaloussi, S., Johansson, H., Lundberg, P., and Langel, U. (2006) Induction of splice correction by cell-penetrating peptide nucleic acids, J Gene Med 8, 1262–1273.
16. Jearawiriyapaisarn, N., Moulton, H. M., Buckley, B., Roberts, J., Sazani, P., Fucharoen, S., Iversen, P. L., and Kole, R. (2008) Sustained dystrophin expression induced by peptide-conjugated morpholino oligomers in the muscles of mdx mice, Mol Ther 16, 1624–1629.
17. Moulton, H. M., Fletcher, S., Neuman, B. W., McClorey, G., Stein, D. A., Abes, S., Wilton, S. D., Buchmeier, M. J., Lebleu, B., and Iversen, P. L. (2007) Cell-penetrating peptide-morpholino conjugates alter pre-mRNA splicing of DMD (Duchenne muscular dystrophy) and inhibit murine coronavirus replication in vivo, Biochem Soc Trans 35, 826–828.
18. Lundin, P., Johansson, H., Guterstam, P., Holm, T., Hansen, M., Langel, Ü., and EL Andaloussi, S. (2008) Distinct uptake routes of cell-penetrating peptide conjugates, Bioconjug Chem 19, 2535–2542.
19. Duchardt, F., Fotin-Mleczek, M., Schwarz, H., Fischer, R., and Brock, R. (2007) A comprehensive model for the cellular uptake of cationic cell-penetrating peptides, Traffic 8, 848–866.
20. El Andaloussi, S., Guterstam, P., and Langel, Ü. (2007) Assessing the delivery efficacy and internalization route of cell-penetrating peptides, Nat Protoc 2, 2043–2047.
21. Mäe, M., El Andaloussi, S., Lundin, P., Oskolkov, N., Johansson, H. J., Guterstam, P., and Langel, Ü. (2009) A stearylated CPP for delivery of splice correcting oligonucleotides using a non-covalent co-incubation strategy, J Control Release 134, 221–227.
22. Futaki, S., Ohashi, W., Suzuki, T., Niwa, M., Tanaka, S., Ueda, K., Harashima, H., and Sugiura, Y. (2001) Stearylated arginine-rich peptides: a new class of transfection systems, Bioconjug Chem 12, 1005–1011.
23. Nakamura, Y., Kogure, K., Futaki, S., and Harashima, H. (2007) Octaarginine-modified multifunctional envelope-type nano device for siRNA, J Control Release 119, 360–367.
24. Kang, S. H., Cho, M. J., and Kole, R. (1998) Up-regulation of luciferase gene expression with antisense oligonucleotides: implications and applications in functional assay development, Biochemistry 37, 6235–6239.
25. Morris, M. C., Depollier, J., Mery, J., Heitz, F., and Divita, G. (2001) A peptide carrier for the delivery of biologically active proteins into mammalian cells, Nat Biotechnol 19, 1173–1176.